Sign In
Buy MBRX
$0.400
-0.620 (-60.78%)
At Close: Jul 31, 2026
Nasdaq Halts Moleculin Biotech Inc.
12:47pm, Monday, 18'th May 2020
NEW YORK, May 18, 2020 -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that the trading halt status in Moleculin Biotech Inc. (Nasdaq: MBRX) was changed to "additional.
UPDATE: Moleculin Biotech, CNS Pharma shares remain halted on Nasdaq
12:08pm, Monday, 18'th May 2020
Moleculin Biotech Inc. and CNS Pharmaceuticals Inc. said Monday their shares remain halted on Nasdaq with the exchange seeking additional information from each company. Shares werehalted temporarily
Moleculin Announces Nasdaq Trading Halt Pending Receipt of Additional Information
11:30am, Monday, 18'th May 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses,
Team of Biochemists and Virologists Discover Potential Targets for COVID-19 Therapy
09:00am, Thursday, 14'th May 2020
Cell culture model: several compounds stop SARS-CoV-2 virus. A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells chang
Coronavirus update: Global case tally tops 4.1 million; South Korea reports cluster from Seoul nightclubs, Wuhan has 4 new cases
04:03pm, Monday, 11'th May 2020
The number of cases of COVID-19 rose above 4.1 million on Monday, as South Korea reported a new cluster stemming from Seoul’s nightclub district and China...
UPDATE: Moleculin Biotech and CNS Pharma comment on SEC trading halt
12:36pm, Monday, 11'th May 2020
Moleculin Biotech Inc. and CNS Pharmaceuticals Inc. said Monday they did not solicit or have any advance knowledge about claims made by third parties about drug candidate WP1122 and its effect on CO
Moleculin Biotech did not solicit claims third parties made about a COVID-19 drug candidate that led to an SEC halt
11:44am, Monday, 11'th May 2020
Moleculin Biotech Inc. undefined said Monday it did not solicit or have any advance knowledge about claims made by third parties about its drug candidate...
Moleculin Provides Additional Comments Regarding Trading Halt
11:30am, Monday, 11'th May 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses,
Investor Alert: Kaplan Fox Investigates Moleculin Biotech, Inc.
09:09pm, Friday, 08'th May 2020
Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Moleculin Biotech, Inc. ("Moleculin" or the "Company") (NASDAQ: MBRX). Investors who purchased Molecul
Moleculin Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 15, 2020
11:30am, Friday, 08'th May 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today annou
SEC Puts the Kibosh on 3 Biotech Stocks Hawking a Miracle Anti-Coronavirus Drug
12:39pm, Wednesday, 06'th May 2020
Since early February, the U.S. Securities and Exchange Commission has issued a series of warnings to investors to beware of companies hawking miracle cures to the disease known as COVID-19. Surely eve
SEC Puts the Kibosh on 3 Penny Stocks Hawking a Miracle Anti-Coronavirus Drug
12:35pm, Wednesday, 06'th May 2020
Since early February, the U.S. Securities and Exchange Commission has issued a series of warnings to investors to beware of companies hawking miracle
Moleculin Biotech, Inc. (MBRX) Flat As Market Gains: What You Should Know
09:45pm, Tuesday, 05'th May 2020
Moleculin Biotech, Inc. (MBRX) closed the most recent trading day at $1.07, making no change from the previous trading session.
Stocks surge as more states move to reopen amid coronavirus
07:11pm, Tuesday, 05'th May 2020
JP Morgan Private Bank Head of Cross-Asset Thematic Strategy Anastasia Amoroso joins Yahoo Finance’s Seana Smith to discuss the latest market action as more states move to reopen their economies in
SEC takes action against three more companies over COVID-19 claims
07:09pm, Tuesday, 05'th May 2020
The Securities and Exchange Commission temporarily halted trading in three more stocks on Monday because of questions regarding the accuracy of information in the marketplace about a drug candidate fo
